AI in Health Care: Balancing Benefits and Barriers
AI can help alleviate the burden on clinical labs—but only with sufficient investment, enthusiasm, and understanding
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
AI can help alleviate the burden on clinical labs—but only with sufficient investment, enthusiasm, and understanding
Two recent studies show that most people see telehealth as a supplement to in-person visits, rather than a replacement.
Without abortion rights, basic lab testing applications for those who are or want to become pregnant have new and ominous legal implications.
New tool helps determine whether immunotherapy is a better option for patients than chemotherapy or radiotherapy.
In a recent report, the GAO says the agency needs a policy when it comes to enforcement discretion regarding tests approved via EUA.
While still in its infancy, recent research shows the combination of AI and wearables can accurately detect early SARS-CoV-2 infection.
New study shows that ctDNA liquid biopsy testing after stage II colon cancer may determine whether chemotherapy is required.
A new study suggests that this is a viable idea, particularly in the context of diabetes screening in a Latinx community.
Inhalers and sensors that offer digital monitoring are beginning to gain FDA approval, and could solve usage issues of traditional products.
Revised guidelines from the American Urological Association support limited use of the tests for certain prostate cancer patients.
The move comes shortly after the FDA said it was going to decline some pre-submission requests to focus on pandemic-related diagnostics.